UK0369,003 + Cialis (Tadalafil)
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Impotence
Conditions
Impotence
Trial Timeline
Feb 1, 2005 → Jun 1, 2005
NCT ID
NCT00174486About UK0369,003 + Cialis (Tadalafil)
UK0369,003 + Cialis (Tadalafil) is a phase 2 stage product being developed by Pfizer for Impotence. The current trial status is completed. This product is registered under clinical trial identifier NCT00174486. Target conditions include Impotence.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00174486 | Phase 2 | Completed |
Competing Products
20 competing products in Impotence
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| tadalafil | Eli Lilly | Approved | 85 |
| tadalafil + sildenafil | Eli Lilly | Approved | 85 |
| tadalafil + placebo + tadalafil + tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| GPI 1485 | Eisai | Phase 2 | 52 |
| tadalafil + sildenafil | Eli Lilly | Approved | 85 |
| tadalafil | Eli Lilly | Approved | 85 |
| tadalafil + sildenafil | Eli Lilly | Phase 3 | 77 |
| tadalafil | Eli Lilly | Phase 3 | 77 |
| tadalafil + placebo + tadalafil + tadalafil | Eli Lilly | Phase 3 | 77 |
| tadalafil + Placebo | Eli Lilly | Phase 3 | 77 |
| tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| tadalafil + tadalafil + placebo | Eli Lilly | Phase 3 | 77 |
| Fluvastatin-sodium | Novartis | Phase 3 | 77 |
| Sildenafil Citrate | Pfizer | Approved | 84 |
| Viagra (Sildenafil citrate) | Pfizer | Approved | 84 |
| sildenafil citrate | Pfizer | Approved | 84 |
| Placebo + Viagra (sildenafil citrate) | Pfizer | Approved | 84 |
| UK-369,003 | Pfizer | Phase 2 | 51 |
| Viagra (Sildenafil Citrate) 100 mg | Pfizer | Approved | 84 |
| Viagra (Sildenafil citrate) | Pfizer | Approved | 84 |